• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

cancer

The AMG 510 model binding the KRAS which is mutant. Binding is irreversible, hindrance constant is viable (nanomolar) in pharmacodynamics terms. Be that as it may, it's effectiveness should be demonstrated clinically. One day this synthetic compound may hit the market and become popular among cancer patients.
March 8, 2021
Pharma Interest

The drug Fenbendazole can make tumors sensitive to radiotherapy just like agents of chemotherapy

Likewise, it was demonstrated by actualizing high throughput screening in-vitro framework that the drug fenbendazole is successful, not just against standard non-small cell lung cancer, NSCLC, yet in addition against the KRAS-mutant malignancy which seems, by all accounts, aggressive, barely accessible by chemotherapy and

More
October 1, 2020

6 Reasons Why Ranitidine Is Harmful and How It Caused Cancer to Many

Ranitidine is a pharmaceutical drug that is categorized as a histamine antagonist,

November 27, 2019

Generic Oncology Drugs Market Holds Promising Opportunities for Small Molecule Modalities

Anticipated to surpass the US$ 20 Billion mark in 2019, generic oncology

The AMG 510 model binding the KRAS which is mutant. Binding is irreversible, hindrance constant is viable (nanomolar) in pharmacodynamics terms. Be that as it may, it's effectiveness should be demonstrated clinically. One day this synthetic compound may hit the market and become popular among cancer patients.
Pharma Interest

The drug Fenbendazole can make tumors sensitive to radiotherapy just like agents of chemotherapy

March 8, 2021

Likewise, it was demonstrated by actualizing high throughput screening in-vitro framework that the drug fenbendazole is successful, not just against

More
Diseases & Health Tips

6 Reasons Why Ranitidine Is Harmful and How It Caused Cancer to Many

October 1, 2020

Ranitidine is a pharmaceutical drug that is categorized as a histamine antagonist, also called an H2 blocker, that has popularly

More
Pharma Interest

The Latest Developments in Mesothelioma Treatment

April 13, 2020

The cases of mesothelioma have been increasing and cause-oriented groups have been lobbying to get companies to properly dispose of

More
Pharma Interest

Generic Oncology Drugs Market Holds Promising Opportunities for Small Molecule Modalities

November 27, 2019

Anticipated to surpass the US$ 20 Billion mark in 2019, generic oncology drugs will witness an increased demand in the

More
Pharmaceutical News

Automated Cell Counters to Witness Robust Demand with High Prevalence of Aids and Cancers

November 13, 2019

Automated cell counters are electronic devices that can automatically count the cells of humans, animals, plants, bacteria, viruses, as well

More
Pharma Interest

How Medical Research Can Tackle the Deadly Legacy of Asbestos

July 9, 2018

Post world war two, the UK had the difficult task ahead of rebuilding cities decimated during the blitz. Asbestos was

More
Pharmaceutical News

BIOCAD demonstrated the use of HeLa cells in oncology research

December 9, 2017

unTOUCHABLE ART, Russia’s first sociocultural trip, was held in Saint-Petersburg in December. BIOCAD, a biotechnology company, demonstrated how “immortal” HeLa

More
Pharmaceutical Articles

The Protein Interaction Between Interleukin-6 and APOBEC3 Provides Insight into Liver Cancer Treatment

November 9, 2017

Liver cancer is the second most common cause of cancer related death worldwide, and hepatocellular carcinoma (HCC) accounts for more

More
Pharma Interest

How are Cancers Found and Diagnosed?

October 15, 2017

Cancer is the plague of the modern age. It is very prevalent, to the point where it is estimated that

More
Pharmaceutical Articles

New Testing Method Could Require Fewer Biopsies for Cancer Patients

December 10, 2015

For a cancer patient, the biopsy is a way of life. During regular screenings after the initial cancer diagnosis, and

More
  • Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers
  • Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform
  • Oral Medication for Erectile Dysfunction
  • Ardena confirms spray drying upgrade and additional capabilities at Spanish site
  • Abzena announces appointment of Petra Dieterich as Scientific Lead

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop